PubRank

J W Mosley

Author PubWeight™ 101.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991 3.02
2 Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981 2.29
3 Pooled plasma derivatives and Creutzfeldt-Jakob disease. Lancet 1995 2.17
4 Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol 1995 2.15
5 Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984 2.01
6 Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med 1977 1.95
7 Factors influencing neonatal infection by hepatitis B virus. Gastroenterology 1973 1.91
8 Viral hepatitis in a group of Boston hospitals. 3. Importance of exposure to shellfish in a nonepidemic period. N Engl J Med 1967 1.75
9 Viral hepatitis in Israel: the effect of canvassing physicians on notifications and the apparent epidemiological pattern. Bull World Health Organ 1972 1.72
10 Subdeterminants d and y of hepatitis B antigen as epidemiologic markers. Am J Epidemiol 1972 1.70
11 Etiology of sporadic hepatitis B surface antigen-negative hepatitis. Ann Intern Med 1977 1.63
12 Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo. J Virol 1997 1.63
13 Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol 1997 1.62
14 A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness. J Infect Dis 1998 1.57
15 An epidemic of clam-associated hepatitis. JAMA 1969 1.55
16 Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 1975 1.50
17 Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis 1996 1.46
18 Hepatitis B virus infection in dentists. N Engl J Med 1975 1.44
19 Viral hepatitis in Israel: morbidity and mortality data. Am J Epidemiol 1970 1.34
20 Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993 1.34
21 Hepatitis as a world problem. Bull N Y Acad Med 1969 1.28
22 An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997 1.24
23 Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group. N Engl J Med 1990 1.22
24 The epidemiology of viral hepatitis: an overview. Am J Med Sci 1977 1.21
25 Hepatits A virus infection in fulminant hepatitis and chronic active hepatitis. Gastroenterology 1978 1.19
26 Hepatitis types B and non-B. Epidemiologic background. JAMA 1975 1.18
27 Viral hepatitis: a group of epidemiologic entities. Can Med Assoc J 1972 1.17
28 Failure to detect an antigen associated with hepatitis in a community epidemic. Nature 1970 1.16
29 Antibodies to hepatitis A virus: patterns by two procedures. J Clin Microbiol 1977 1.14
30 A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci 1991 1.13
31 Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr 1992 1.12
32 Serologic characterization of patients with two episodes of acute viral hepatitis. Am J Med 1975 1.07
33 Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute. N Engl J Med 1975 1.06
34 Potency of fragmented IgG: two studies of postexposure prophylaxis in type A hepatitis. J Lab Clin Med 1975 1.05
35 Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis. Am J Epidemiol 1968 1.05
36 Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group. N Engl J Med 1993 1.02
37 Epidemiologic nomenclature for hepatitis B virus transmission. Am J Epidemiol 1980 1.01
38 Similarities of two hepatitis A virus strains. Bull World Health Organ 1976 1.00
39 Non-A, non-B hepatitis transmission in chimpanzees: a project of the transfusion-transmitted viruses study group. Intervirology 1978 1.00
40 Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States. Gastroenterology 1993 0.98
41 Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. BMJ 1992 0.98
42 Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis 1995 0.97
43 Viral hepatitis as an occupational hazard of dentists. J Am Dent Assoc 1975 0.94
44 Rapid molecular epidemiology of human immunodeficiency virus transmission. AIDS Res Hum Retroviruses 1995 0.93
45 Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.92
46 Harry G. Armstrong lecture: Global travel and travelers' health. Aviat Space Environ Med 1980 0.91
47 Transfusion-transmitted viruses study: experimental evidence for two non-A, non-B, hepatitis agents. J Infect Dis 1980 0.90
48 Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group. Transfusion 1991 0.89
49 Naturally occurring hepatitis B virus mutants with deletions in the core promoter region. J Hepatol 1994 0.89
50 Who should be our blood donors? Transfusion 1991 0.88
51 Divergence of HIV-1 quasispecies in an epidemiologic cluster. AIDS 1997 0.88
52 Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology 1981 0.87
53 A virologically studied epidemic of type A hepatitis in a school for the mentally retarded. Am J Epidemiol 1981 0.87
54 Viral hepatitis: enzyme assays and serologic procedures in the study of an epidemic. Am J Epidemiol 1977 0.87
55 Hepatitis A antibody in West Africa. Lancet 1980 0.87
56 Fecal excretion of hepatitis A virus in humans. J Infect Dis 1977 0.87
57 Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion 1990 0.85
58 Transfusion-asociated viral hepatitis. Anesthesiology 1966 0.85
59 Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1997 0.84
60 Viral hepatitis among American missionaries abroad. A preliminary study. JAMA 1967 0.84
61 Viral hepatitis: recent studies of etiology. Prog Liver Dis 1970 0.84
62 Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. Ann Intern Med 1990 0.83
63 Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders. Pediatrics 1991 0.83
64 Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates? Transfusion 1994 0.83
65 Subtypes of hepatitis B antigen among Israeli blood donors. Vox Sang 1973 0.83
66 Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply. Transfusion 2000 0.82
67 Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group. Transfusion 1992 0.82
68 Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet 1988 0.81
69 Hepatitis A virus infection in households. Am J Epidemiol 1982 0.81
70 Chimpanzee-associated viral hepatitis in 1963. Am J Epidemiol 1967 0.80
71 Fragmented IgG for post-exposure prophylaxis of type A hepatitis. Transfusion 1973 0.79
72 Prognostic implications of the e antigen of hepatitis B virus. JAMA 1977 0.79
73 Hepatitis-A-virus exposure in the Gambia. Lancet 1979 0.78
74 Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. Blood 1992 0.78
75 Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study Group. Vox Sang 1990 0.78
76 Editorial: The HBV carrier--a new kind of leper? N Engl J Med 1975 0.77
77 Lack of dual HIV infection in a transfusion recipient exposed to two seropositive blood components. AIDS Res Hum Retroviruses 1996 0.77
78 Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study Group. Transfusion 1993 0.77
79 Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group. Transfusion 1994 0.77
80 Hematologic profile and lymphocyte subpopulations in hemoglobin SC disease: comparison with hemoglobin SS and black controls. The Transfusion Safety Study Group. Am J Hematol 1996 0.76
81 Letter: Corticosteroids in fulminant hepatitis. N Engl J Med 1976 0.76
82 Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr 1991 0.76
83 Virus transmission in health care settings: precautions, epidemiologic experience, and common sense. Am J Public Health 1993 0.75
84 Is safe always safe? Pooled plasma derivatives and viral hepatitis. Gastroenterology 1996 0.75
85 Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group. Blood 1993 0.75
86 Chimpanzee-associated hepatitis. An outbreak in Oklahoma. JAMA 1967 0.75
87 Hepatitis C virus transmission by intravenous immunoglobulin. Lancet 1995 0.75
88 Blood donations and viruses. Lancet 1997 0.75
89 Safety of factor VIII. Ann Intern Med 1991 0.75
90 Immunoglobulin M level in the diagnosis of type A hepatitis. Am J Clin Pathol 1981 0.75
91 Passive antibody to hepatitis A virus in US haemophiliacs. Lancet 1993 0.75
92 Hepatitis C virus and intravenous immune globulin. JAMA 1997 0.75
93 Transmission of hepatitis C by pasteurised factor VIII. Lancet 1992 0.75
94 Vertical transmission of type B hepatitis. JAMA 1972 0.75
95 Potency evaluation of gamma globulin against posttransfusion hepatitis. Further comment on gamma globulin potency. Am J Epidemiol 1969 0.75
96 A zoonosis associated with African green monkeys. J Am Vet Med Assoc 1968 0.75
97 Isoniazid toxicity. JAMA 1971 0.75
98 Immunization advisory memoranda re plague and cholera. Med Ann Dist Columbia 1968 0.75
99 Hepatitis B immune globulin: some progress and some problems. Ann Intern Med 1979 0.75
100 Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am J Clin Pathol 1989 0.75
101 Post-transfusion hepatitis: analysis of risk factors. Acta Haematol Pol 1981 0.75
102 The sea, sewage, and salubrity. N Engl J Med 1969 0.75
103 Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group. Lancet 1993 0.75
104 The search for human hepatitis viruses. Arch Gesamte Virusforsch 1967 0.75
105 Hepatitis B virus exposure of hospital staff. J Occup Med 1980 0.75
106 Present knowledge of viral hepatitis. Int Dent J 1984 0.75
107 Re: "'Nosocomial': a broader perspective?". Am J Epidemiol 1987 0.75
108 Transfusion-transmitted viral hepatitis. Clin Lab Med 1982 0.75
109 Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group. Blood 1994 0.75
110 Hepatitis B virus subtypes ad and ay among blood donors in the Greater Los Angeles area. Transfusion 1974 0.75
111 The blood brain barrier in relation to viruses. JAMA 1967 0.75
112 Stability of serum-glutamic pyruvic transaminase activity on storage. Tech Bull Regist Med Technol 1965 0.75
113 Transaminase levels in the postconvalescent phase of infectious hepatitis. JAMA 1967 0.75
114 Viral hepatitis in Israel. Transfusion-associated hepatitis. Transfusion 1972 0.75
115 Hepatitis B virus. The importance of "nonepidemics". Am J Dig Dis 1978 0.75
116 Some remarks of HBsAg and anti-HBs distribution in symptom-free carriers. Arch Roum Pathol Exp Microbiol 1978 0.75
117 Low CD4+ counts in a study of transfusion safety: correction. N Engl J Med 1993 0.75
118 Statistical approaches to evaluating prognostic indices in HIV infection. The Transfusion Safety Study Group. AIDS 1991 0.75
119 Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group. Lancet 1990 0.75
120 Type A hepatitis. Med Clin North Am 1975 0.75
121 Viral hepatitis: lack of transmission in an Athenian School. Int J Epidemiol 1978 0.75
122 Foundling viruses and transfusion medicine. Transfusion 1999 0.75